Ask AI
H.R. 3968

Stop Meth Labs and Enhance Patient Access Act of 2015

Stop Meth Labs and Enhance Patient Access Act of 2015

This bill amends the Controlled Substances Act to revise the standard used by the Drug Enforcement Administration (DEA) to determine whether to exempt a scheduled listed chemical product from certain applicable requirements. (A scheduled listed chemical product is a nonprescription drug product that contains ephedrine, pseudoephedrine, or phenylpropanolamine.)

Currently, the DEA may exempt retail sales of a scheduled listed chemical product from certain requirements (e.g., daily sales limits) if the product cannot be used to illegally manufacture methamphetamine. This bill allows the DEA to exempt retail sales of a scheduled listed chemical product from such requirements if it is not practical by processes known to be employed by clandestine laboratory operators to use the product to illegally manufacture methamphetamine.

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Rep. Guinta, Frank C. [R-NH-1](R-NH)Sponsor
2committees7actions5subjects
  1. Committee

    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    Crime and Federal Government Surveillance Subcommittee
  2. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  3. IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  4. IntroReferralH11100-A

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  6. IntroReferralIntro-H

    Introduced in House

  7. IntroReferral1000

    Introduced in House

Stop Meth Labs and Enhance Patient Access Act of 2015 — Informed